Mertens Steve's Insider Trades & SAST Disclosures

Mertens Steve's most recent trade in NeuroOne Medical Technologies Corp was a trade of 7,376 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Feb. 18, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. 18 Feb 2025 7,376 164,047 - 1.2 8,556 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. 31 Jan 2025 252 171,423 - 1.2 290 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. 31 Dec 2024 1,158 171,675 - 0.8 957 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. 30 Nov 2024 252 172,833 - 0.6 157 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. 31 Oct 2024 252 173,085 - 1.0 244 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. 30 Sep 2024 1,158 173,337 - 1.0 1,146 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. 31 Aug 2024 252 174,495 - 0.8 201 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. 31 Jul 2024 252 174,747 - 0.8 189 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. 30 Jun 2024 1,158 174,999 - 0.8 926 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. 31 May 2024 252 176,157 - 0.9 234 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 30 Apr 2024 252 176,409 - 1.1 285 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. 21 Apr 2024 7,250 176,661 - 1.2 8,338 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 31 Mar 2024 252 183,911 - 1.2 302 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. 29 Feb 2024 252 184,163 - 1.2 305 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2024 101,743 184,415 - 0 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. 31 Jan 2024 252 82,672 - 1.3 315 Common Stock
NeuroOne Medical Technolog...
Mertens Steve Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. 31 Dec 2023 252 82,924 - 1.6 398 Common Stock
NeuroOne Medical Technolog...
Mertens Steve Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. 30 Nov 2023 252 83,176 - 1.4 365 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. 31 Jul 2023 252 84,436 - 1.0 257 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 30 Jun 2023 252 84,688 - 1.2 302 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. 31 May 2023 252 84,940 - 1.2 305 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. 30 Apr 2023 252 85,192 - 1.5 388 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2023 50,000 85,444 - 0 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2023 50,000 50,000 - - Option to Purchase Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.61 per share. 31 Mar 2023 252 35,444 - 1.6 406 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 03 Feb 2023 6,054 35,696 - 1.5 8,899 Common Stock
NeuroOne Medical Technolog...
Steve Mertens Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2022 41,750 41,750 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades